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Introduction
 
Type 1 diabetes mellitus (T1D; OMIM 222100) is an autoimmune
disease. The destruction of insulin-secreting 
 
β
 
-cells of the islets
of Langerhans leads to hyperglycaemia, which is a key factor
in the development of diabetic microvascular complications such
as retinopathy, nephropathy and neuropathy. The development
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Abstract
 
Aim
 
The intercellular adhesion molecule-1 (ICAM-1) gene is located on chromo-
some 19p13, which is linked to Type 1 diabetes (T1D). ICAM-1 expression is
related to development of T1D and diabetic nephropathy. The present study
aims to evaluate the genetic influence of ICAM-1 gene polymorphisms on the
development of T1D and diabetic nephropathy.
 
Methods
 
Five valid single nucleotide polymorphisms (SNPs) were genotyped in 432
T1D patients (196 patients had diabetic nephropathy) and 187 non-diabetic control
subjects by using dynamic allele-specific hybridization (DASH) and pyrosequencing.
 
Results
 
SNPs rs281432(C/G) and rs5498 E469K(A/G) had high heterozygous
indexes. They were significantly associated with T1D [
 
P
 
 = 0.026, OR = 1.644 (95%
CI 1.138–2.376) and 
 
P
 
 < 0.001, OR = 2.456 (1.588–3.8)]. Frequencies of the
C allele in SNP rs281432(C/G) and the A allele in SNP rs5498 E469K(A/G)
increased stepwise from non-diabetic control subjects to T1D patients without
diabetic nephropathy and T1D patients with diabetic nephropathy. Further
analysis for these two SNPs indicated that T1D patients had increased frequency
of the common haplotype C-A, in comparison with non-diabetic control sub-
jects (38.1 vs. 32.1%, 
 
P
 
 = 0.035).
 
Conclusion
 
The present study provided evidence that SNPs rs281432(C/G) and
rs5498 E469K(A/G) in the ICAM-1 gene confer susceptibility to the development
of T1D and might also be associated with diabetic nephropathy in Swedish Caucasians.
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of T1D and diabetic complications is strongly modulated by
genetic and environmental factors [1]. Identification of the
genes predisposing for T1D and its specific microvascular
pathology and dissection of genotypic and phenotypic interactions
are of importance for better understanding of the pathogenesis
of T1D and mechanism of vascular damage.
To date, several loci conferring susceptibility to T1D have
been identified, i.e. the human leucocyte antigen complex in
chromosome 6p21.3, the insulin gene in 11p15.5 and the
cytotoxic T lymphocyte-associated antigen-4 (CTLA4) gene in
2q33.2 [2]. Furthermore, genome-wide scans have predicted
that T1D susceptibility genes may reside at other chromosomal
regions, including chromosome 19p13 [2–4]. The intercellular
adhesion molecule (ICAM-1) gene is located in this chromo-
somal region. ICAM-1 is a 90-kDa cell surface glycoprotein
belonging to the immunoglobulin superfamily and it is involved
in the firm attachment of leucocytes to endothelium [5,6].
It is normally expressed at low levels on the surface of arterial
endothelial cells. ICAM-1 mRNA and protein of ICAM-1 were
reported to be increased by hyperglycaemia [7,8]. In experi-
mental studies using T1D animal models, increased ICAM-1
expression accompanies progression of T1D [9] and also
diabetic nephropathy [10,11]. Inhibition of ICAM-1 expression
in non-obese diabetic mice prevents or delays the onset of T1D
[12]. Clinical studies indicate that the level of plasma adhesion
molecule is elevated in T1D patients [13,14]. Furthermore, it
has been proposed that the increased levels of plasma adhesion
molecule may be a sign of pre-clinical T1D in children [15].
Therefore, the ICAM-1 gene represents a strong positional and
biological candidate for the susceptibility to the development
of T1D and diabetic nephropathy.
In the last 7 years, several genetic association studies for the
ICAM-1 gene in T1D have been published. All these previous
studies were designed for analysis of one or two single nucleotide
polymorphisms (SNPs) in the ICAM-1 gene, and conflicting
results were reported. Guja 
 
et al
 
. first demonstrated that the
transmission of the G allele of SNP K469E(A/G) was increased
in Romanian T1D families [16]. Nishimura 
 
et al
 
. found this
SNP to be associated with adult-onset T1D patients in Japanese
subjects [17]. However, the association of this SNP with T1D
was not found in Danish, Finnish and British Caucasians [18,19].
Furthermore, Nejentsev 
 
et al
 
. reported that another non-
synonymous SNP G241R(G/A) in the ICAM-1 gene was
associated with T1D. The G241 allele was highly transmitted
in T1D families of Finnish, British, Romanian, European and
American Caucasian origin [20]. The aim of the present study
was to determine the genetic influence of the ICAM-1 gene
polymorphisms in the development of T1D and diabetic
nephropathy. We have therefore conducted a comprehen-
sive genetic association study for five SNPs in the ICAM-1
gene, including the previously studied SNPs, i.e. K469E(A/
G) and G241R(G/A). All 432 T1D patients and 187 non-
diabetic control subjects who participated in the study were
Swedish Caucasians. Of the T1D patients, 196 had diabetic
nephropathy.
 
Patients and methods
 
Subjects
 
A group of 432 (women 234/men 198) patients with T1D were
included in the present study. The patients were diagnosed
according to the World Health Organization criteria (WHO
1985 [21]). All patients with T1D had urinary albumin excretion
rate (UAER) measured in at least two consecutive overnight
urine samples. One hundred and ninety-six (103/93) T1D patients
had diabetic nephropathy (UAER 
 
≥
 
 20 
 
µ
 
g/min); 187 (116/71)
non-diabetic healthy individuals, with no family history of
diabetes, served as control subjects. All T1D patients and
non-diabetic control subjects were Swedish Caucasians. Clinical
characteristics of all subjects are summarized in Table 1. Informed
consent was obtained from all subjects and the study was
approved by the local ethics committees. Genomic DNA was
extracted from peripheral blood using a Puregene DNA purifica-
tion kit (Gentra, Minneapolis, MN, USA).
 
SNPs selection and validation
 
All SNPs in the ICAM-1 gene selected for the present study are
recorded in the public dbSNP database. The SNP ID numbers
and detailed sequence information are publicly available (http://
www.ncbi.nlm.nih.gov/SNP/). Eight SNPs were selected for study.
Non-diabetic
controls
All T1D 
patients
T1D without 
diabetic 
nephropathy
T1D with 
diabetic 
nephropathy
n (M/F) 187 (71/116) 432 (198/234) 236 (105/131) 196 (93/103)
Age (years)  48 ± 5  45 ± 12  44 ± 12  46 ± 12
Duration (years) —  31 ± 11  29 ± 10  34 ± 12
BMI (kg/m2) 23.0 ± 1.82 25.3 ± 3.44 24.6 ± 3.08 25.8 ± 3.65
SBP (mmHg)  118 ± 14  132 ± 19  126 ± 15  138 ± 21
DBP (mmHg)  73 ± 9  76 ± 9  73 ± 8  78 ± 10
HbA1c (%) — 7.2 ± 1.25 7.0 ± 1.15 7.4 ± 1.35
All data, mean ± SD.
BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Table 1 Clinical characteristics of T1D 
patients and non-diabetic control subjects 
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For each SNP, 32 DNA samples from Swedish Caucasians were
used to test the frequency of the polymorphisms. The allele
frequencies of three SNPs, i.e. rs5490, rs5030348 and
rs5495(M56K), which are located, respectively, in the 5
 
′
 
untranslated region, intron 1 and exon 5, were lower than 1%
in our population. These three SNPs were thus excluded and the
remaining five SNPs were selected for further genotyping experi-
ments in the larger set of samples.
 
SNP genotyping and sequencing analysis
 
We have used a high-throughput SNP scoring technique called
dynamic allele-specific hybridization (DASH [22]). PCR-DASH
assays were designed for genotyping all SNPs and the sequence
information for all primers and probes designed are given
in Table 2. To confirm DASH genotyping data for SNPs
rs281432(C/G) and rs5498 E469K(A/G), which were found to
be associated with T1D, we have used another high-throughput
genotyping method, i.e. pyrosequencing [23] with the same
primers as used in the DASH assays.
To further examine whether ‘duplicons’ were involved in the
ICAM-1 gene, the genomic sequences around SNPs rs281432(C/
G) and rs5498 E469K(A/G) were PCR-amplified. The sizes of
the PCR-amplified fragments are 419 and 511 bp, respectively,
for SNPs rs281432(C/G) and rs5498 E469K(A/G). The direct
sequencing analysis using Big Dye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA,
ABI, model 377 genetic analyser, Perkin-Elmer, Shetton, CT, USA)
was performed. The sequences of the primers and optimized
PCR conditions are available on request.
 
Bio-informatics
 
Description of the positions of all SNPs was accorded to the
genomic contig sequences (accession no. NT_011295). The
sequence alignment analysis for all SNPs and the designed
assays in human genome was performed using BLAST. The
possible structures of PCR products for DASH genotyping
experiments were detected with mFold (version 3.1; http://
www.bioinfo.rpi.edu/applications/mfold/old/dna/).
 
Statistical analyses
 
Deviation from the Hardy–Weinberg equilibrium for alleles in
each SNP was assessed using the appropriate Chi-square dis-
tributed statistics. For differences between T1D patients and
non-diabetic control subjects, two models were tested com-
paring either allele frequencies in 2 
 
×
 
 2 contingency tables or
genotypes in 3 
 
×
 
 2 contingency tables. Tests for association
between genotypes and quantitative traits were performed
using Kruskal–Wallis analysis of ranks for traits with non-normal
distributions, or alternatively, 
 
ANOVA
 
 for normally distributed
traits. For association estimation, odds ratios (OR) and 95%
confidence intervals (CI) were estimated with unconditional
logistic regression models between case and control (T1D
patients and non-diabetic individuals) groups. All statistical
analyses were performed using the BioMedical Data Program
(BMDP) version 1.12 and/or STATISTICA version 7.0. Linkage
disequilibrium (LD) was carried out using our own algorithms
and Arlequin program (http://lgb.unige.ch/arlequin/ in 
 
r
 
2
 
 and/or
D
 
′
 
). Heterogeneity in haplotype frequency distribution between
T1D and control groups was tested by calculating the test
statistic 2*(log-likelihood
 
T1D
 
 + log-likelihood
 
Control
 
 
 
−
 
 log-
likelihood
 
Combined
 
), which has a 
 
χ
 
2
 
 distribution with 
 
n
 
-1 degrees
of freedom (
 
n
 
 is the number of haplotypes).
 
Results
 
The allele frequencies of five SNPs in the ICAM-1 gene are given
in Table 3. No significant differences in the allele frequencies
were found between the groups of T1D patients and non-diabetic
control subjects. However, there were significant differences
of genotype distribution in SNPs rs281432(C/G) (
 
P =
 
 0.026)
and rs5498 E469K(A/G) (
 
P <
 
 0.001) between all T1D patients
and non-diabetic control subjects (Table 3). The comparison
analysis for CC + CG vs. GG in SNP rs281432(C/G) between
T1D patients and non-diabetic control subjects indicated that
this SNP was associated with T1D [OR = 1.644 (95% CI 1.138–
2.376), 
 
P
 
 = 0.008)]. In SNP rs5498 E469(A/G), similar results
were found, suggesting that the SNP was associated with T1D
SNP ID Oligo name Sequence
rs5491 ICAM1–09F 5′- TGACATGCAGtACCTCCTGTGACC-3′
ICAM1b10R 5′-Biotin-TTAGGCAACGGGGTCTCTATGTCC-3′
ICAM1–11paRox 5′-CCAGCCCAAGTTGTTGG-Rox-3′
rs281432 ICAM1–13F 5′-CTTGGGGTGATAGGGAGTCATG-3′
ICAM1b14R 5′-Biotin-CCTTCAGCTATCTAATCCCTGG-3′
ICAM1–15pcRox 5′-GAGGGTTTCTGAGCAGG-Rox-3′
rs5492 ICAM1b17F 5′-Biotin-GTGGTGCTGCTCaGTGGGGAGA-3′
ICAM1–18R 5′-CACATCTGGCTCCCGTTTCAGCT-3′
ICAM1–19pcRox 5′-TTCAGCTCCTTCTCCCCA-Rox-3′
rs1799969 ICAM1–21F 5′-GGGGACCATGGTCTGTTCACTGGA-3′
ICAM1b22R 5′-Biotin-ACCTGGTCCTCCGAGACTGTGAACA-3′
ICAM1–23pgRox 5′-CACTGGACGGGCTGTTCAC-Rox-3′
rs5498 ICAM1–29F 5′-AGGAGCACTCAAtGGGAGGTCAtCCG-3′
ICAM1b30R 5′-Biotin-ACTCACAGAaCACATTCACGGTaACC-3′
ICAM1–31pgRox 5′-TCAtCCGCGAGGTtACC-Rox-3′
Table 2 The primers and probes used in PCR-
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[OR = 2.456 (1.588–3.800), P = 0.001 for AA + AG vs. GG].
There was no significant difference in genotype distributions
of SNPs rs5491(A/T), rs5492(C/G) and rs1799969 R241G(A/
G) between the case and control groups studied.
We found that SNP rs281432(C/G) and rs5498 E469K(A/G)
had high heterozygous indexes, although the genotype dis-
tributions of SNPs studied in non-diabetic individuals were
in the Hardy–Weinberg equilibrium. We thus performed and
confirmed the genotyping experiments by using DASH and
pyrosequencing. Data using both techniques were matched,
and no indication of genotyping error was found. To ascertain
whether ‘duplicons’, which might cause high heterozygous
indexes, were involved in these two SNPs, direct sequencing
analysis by using forward and reverse primers was performed,
but no ‘duplicons’ were found.
We attempted to detect possible association of SNPs
rs281432(C/G) and rs5498 E469K(A/G) with diabetic
nephropathy, although no significant difference of genotype
distribution in these two SNPs between the groups of T1D
patients with diabetic nephropathy and the patients without
diabetic nephropathy was found (Table 4). We dissected the
allele frequencies for these two SNPs in non-diabetic control
subjects, T1D patients without nephropathy and T1D patients
with nephropathy. Results indicated that frequencies of the
C allele in SNP rs281432(C/G) and the A allele of SNP rs5498
E469K(A/G) increased gradually from non-diabetic control
subjects (40.1 and 51.1%, respectively), to T1D patients
without diabetic nephropathy (44.5 and 54.7%), and to T1D
patients with diabetic nephropathy (47.2 and 57.4%; Figs 1a
and b).
To further search for evidence that ICAM-1 gene polymor-
phisms influence the development of T1D, the degree of LD for
all SNPs was examined. Data indicated that the ICAM-1 gene
had a low LD (Table 5) and the average probability of haplo-
type interference across the dataset was moderate. However,
a relatively strong LD (|D′| = ∼0.7) appeared to extend over the
region between SNPs rs281432(C/G) and rs5498 E469K(A/G).
Frequencies of haplotypes constructed by these two SNPs in
T1D patients and non-diabetic control subjects are summa-
rized in Table 6. Four common haplotype (with at least 5%
frequency) including C-A, C-G, G-G and G-A were examined.
The haplotype C-A frequency was significantly higher in
T1D patients than in non-diabetic control subjects (38.1 vs.
32.1%, P = 0.035).
Table 3 Allele frequencies of SNPs in the ICAM-1 gene
SNP ID Location
Contig 
position*
IUB 
DNA code Group Alleles
Allele 
frequency P-value
rs5491 Exon 2 1648342 K56M ND T 368 A 4 T0.989/A0.011 NS
W = A/T T1D  T 893 A 5 T0.994/A0.006
rs281432 Intron 2 1653460 Intronic ND  G 224 C 150  G0.599/C0.401  0.069
S = C/G T1D  G 467 C 393 G0.543/C0.457
rs5492 Exon 3 1657092 N155K ND  G 369 C 3 G0.992/C0.008  NS
S = C/G T1D  G 851 C 11 G0.987/C0.013
rs1799969 Exon 4 1657594 R241G  ND  G 320  A 52 G0.860/A0.140  NS
R = A/G T1D G 718 A 136 G0.841/A0.159
rs5498 Exon 6 1658485 E469K ND  A 191  G 183 A0.511/G0.489  NS
R = A/G T1D A 481 G 379 A0.559/G0.441
*Contig accession no. NT_011295.
ND, non-diabetic control subjects; NS, not significant.
Table 4 Genotype distributions of SNPs rs281432 and rs5498
SNP ID Groups Genotypes P-value OR (95% CI) P-value
CC CG GG CC + CG vs. GG CC + CG vs. GG
rs281432 Non-diabetic control subjects 30 90 67
All T1D patients 72 249 109  0.026* 1.644 (1.138–2.376) 0.008*
T1D without diabetic nephropathy 35 139 61
T1D with diabetic nephropathy 37 110 48  0.529† 1.074 (0.693–1.663) 0.750†
AA AG GG AA + AG vs. GG AA + AG vs. GG
rs5498 Non-diabetic control subjects 52 87 48
All T1D patients 104 273 53 < 0.001* 2.456 (1.588–3.800) 0.001*
T1D without diabetic nephropathy 50 156 28
T1D with diabetic nephropathy 54 117 25  0.279† 1.076 (0.605–1.914) 0.804†
P-value: *All T1D patients vs. non-diabetic control subjects; †T1D patients with nephropathy vs. T1D patients without nephropathy.Original article 1097
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Discussion
We have carried out a genetic association study of five SNPs in
the ICAM-1 gene in Swedish T1D patients and non-diabetic
control subjects with a high-throughput SNP scoring technique
called DASH. The results indicated that SNPs rs281432(C/G)
and rs5498 E469K(A/G) were significantly associated with the
development of T1D. Interestingly, these two SNPs had a high
heterozygous index in the genotype distribution. We thus
confirmed the genotyping experiments by using pyrosequencing.
Segmental duplications (duplicons) with > 90% similarity
between copies comprise at least 5% of the human genome,
which may cause specific allelic and genotypic diversities,
such as a high heterozygous index in complex diseases [24,25].
In order to ascertain whether the duplicons are involved in the
regions around the SNPs studied, we performed direct sequenc-
ing analysis for the subjects with the heterozygous genotypes
and found that no duplicon was involved. In the previous genetic
association studies of SNP rs5498 E469K(A/G) in T1D, the
information concerning genotype distribution of this SNP was
unclear [18–20]. We therefore communicated with the authors
of previous reports. The summary of genetic association study
of this SNP in different ethnic populations in the previous and
present studies (Table 7) indicates that the phenomenon of
high heterozygous index of this SNP exists in all populations
studied. The high heterozygous index may cause a ‘type 1
error’ in genetic-association analysis. Indeed, no significant
difference of the allele frequencies of this SNP between T1D
patients and non-diabetic control subjects was observed in the
present study. By comparison analysis of genotype distribu-
tions, however, we were able to detect association of the
polymorphisms with T1D. Based on the findings in the present
study and the previous reports [16,17], we conclude that the
heterozygous genotypes of SNPs rs281432(C/G) and rs5498
E469K(A/G) in the ICAM-1 gene may confer disease risk.
Rs5498 E469K(A/G) is a non-synonymous SNP and resides
in the fifth immunoglobulin-like domain of ICAM-1. To date,
no report indicates that this domain is involved in ligand
binding of ICAM-1. However, this domain may play a role in
an immunodominant epitope of B lymphocytes and dendritic
cells [26]. A recent study has demonstrated that this SNP
affects ICAM-1 mRNA splicing pattern and TPA-induced
Figure 1 Allele distribution of SNPs (a) 
rs281432(C/G) and (b) rs5498 E469K(A/G). 
Group 1, non-diabetic control subjects; 
group 2, T1D patients without diabetic 
nephropathy; group 3, T1D patients with 
diabetic nephropathy; (a)  , allele C;   , 
allele G; (b)  , allele A;   , allele G.
Table 5 Pair-wise LD values for SNPs in the ICAM-1 gene
|D′| 
SNPs rs5491 rs281432 rs5492 rs1799969 rs5498
rs5491 —  1.000 1.000 0.076 0.374
rs281432 0.003  — 0.616 0.127 0.689
rs5492 0.775  0.009 — 0.325 0.621
rs1799969 0.932  0.034 0.004 — 0.296
rs5498 0.363 < 0.001 0.018 0.001 —
P-value
Table 6 The frequencies of haplotypes constructed by SNPs rs281432(C/
G) and rs5498 E469K(A/G)
Haplotypes
Non-diabetic 
control subjects
All T1D 
patients P-value
C-A 0.321 0.381 0.035
C-G 0.080 0.074 NS
G-G 0.409 0.363 NS
G-A 0.190 0.173 NS
Table 7 Comparison analysis of SNP rs5498 E469K(A/G) genotype distribution in four ethnic populations
Population
Non-diabetic control subjects (%) T1D patients (%)
Reference n AA AG GG n AA AG GG
Swedish 187 27.8 46.5 25.7 432 24.2 63.5 12.3 The present study
Danish 461 31.7 49.4 18.9 252 27.4 56.7 15.9 Kristiansen et al. 2000 [19]
Finnish 212 24.1 50.0 25.9 218 26.6 47.2 26.1 Nejentsev et al. 2000 [18]
Japanese 171 12.3 50.9 36.8 164 18.3 47.0 34.7 Nishmura et al. 2000 [17]1098 Association of the ICAM-1 gene with T1D • J. Ma et al.
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apoptosis [27]. In accordance with genetic association studies
of this SNP in the present and previous reports [16,17], we
suggest that SNP rs5498 E469K(A/G) has a genetic and
biological influence related to the pathogenesis of T1D.
Single marker analysis is a useful tool for genetic association
studies. Multiplex marker analysis, however, may be more
powerful for detecting an association in complex diseases.
All previous genetic association reports of the ICAM-1 gene in
T1D studied only one or two SNPs, which may reduce the
possibility of detecting an association. In the present study, we
genotyped five SNPs along the ICAM-1 gene and performed
a haplotype analysis based upon population-specific LD. We
found that SNP rs281432(C/G) and rs5498 E469K(A/G) might
exist in an LD block. The common haplotype C-A of these two
SNPs was found to be significantly associated with T1D in
Swedish Caucasians. Previously, Nejentsev et al. found that
SNP rs1799969 R241G(A/G) had an increased transmission
rate in T1D patients [20]. This non-synonymous SNP is located
between SNPs rs281432(C/G) and rs5498 E469K(A/G), which
were not found to be associated with T1D in our population,
most likely because of specific population LD diversities.
Biological experiments suggest that genetic variation of the
ICAM-1 gene might be involved in the development of diabetic
nephropathy [10,11]. To test this hypothesis, we have dissected
frequency and distribution of the alleles in SNPs rs281432(C/
G) and rs5498 E469K(A/G) among non-diabetic control
subjects, T1D patients without nephropathy and T1D patients
with nephropathy. Frequencies of the C allele of SNP rs281432(C/
G) and the A allele of SNP rs5498 E469K(A/G) increased
gradually, suggesting that most likely these alleles confer
risk in the developmental process of T1D and also diabetic
nephropathy. However, the differences in the allele frequencies
and genotype distributions did not reach statistical significance
when comparing T1D patients with and without diabetic
nephropathy. The sample size is one of the critical components
for a successful genetic-association study. The sample size for
T1D with nephropathy in the present study and also in the
previous reports [17–19] was relatively limited as a result of
the difficulty of sample collection.
In conclusion, the C allele of SNP rs281432(C/G) and the
A allele of SNP rs5498 E469K(A/G) in the ICAM-1 gene are
significantly associated with T1D in Swedish Caucasians.
These two alleles confer an increased risk for the development
of T1D and might also be associated with susceptibility to
diabetic nephropathy.
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